Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02753127
Title A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer (CanStem303C)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications

colorectal cancer

Therapies

Fluorouracil + Irinotecan + Leucovorin

Napabucasin

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.